{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:24:12Z","timestamp":1764689052992},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4280","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T22:01:41Z","timestamp":1431640901000},"page":"1237-1241","source":"Crossref","is-referenced-by-count":3,"title":["Congenital Contractural Arachnodactyly without <i>FBN1<\/i> or <i>FBN2<\/i> Gene Mutations Complicated by Dilated Cardiomyopathy"],"prefix":"10.2169","volume":"54","author":[{"given":"Hiroki","family":"Yagi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Translational Research for Healthcare and Clinical Science, The University of Tokyo Hospital, Japan"},{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Kanamori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shimada Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shimada Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Akazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, The University of Tokyo Hospital, Japan"},{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Callewaert BL, Loeys BL, Ficcadenti A, et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Hum Mutat 30: 334-341, 2009.","DOI":"10.1002\/humu.20854"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Frederic MY, Monino C, Marschall C, et al. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum Mutat 30: 181-190, 2009.","DOI":"10.1002\/humu.20794"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cook JR, Carta L, Benard L, et al. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest 124: 1329-1339, 2014.","DOI":"10.1172\/JCI71059"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alpendurada F, Wong J, Kiotsekoglou A, et al. Evidence for Marfan cardiomyopathy. Eur J Heart Fail 12: 1085-1091, 2010.","DOI":"10.1093\/eurjhf\/hfq127"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kiotsekoglou A, Moggridge JC, Bijnens BH, et al. Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome. Eur J Echocardiogr 10: 947-955, 2009.","DOI":"10.1093\/ejechocard\/jep110"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Matsumoto T, Watanabe A, Migita M, et al. Transient cardiomyopathy in a patient with congenital contractural arachnodactyly (Beals syndrome). J Nippon Med Sch 73: 285-288, 2006.","DOI":"10.1272\/jnms.73.285"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ogawa N, Imai Y, Takahashi Y, et al. Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene. Am J Cardiol 108: 1801-1807, 2011.","DOI":"10.1016\/j.amjcard.2011.07.053"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Devereux RB, deSimone G, Arnett DK, et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons >\/=15 years of age. Am J Cardiol 110: 1189-1194, 2012.","DOI":"10.1016\/j.amjcard.2012.05.063"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 47: 476-485, 2010.","DOI":"10.1136\/jmg.2009.072785"},{"key":"10","unstructured":"10. Su PH, Hou JW, Hwu WL, et al. Congenital contractural arachnodactyly (Beals syndrome). Acta Paediatr Taiwan 41: 59-62, 2000."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gupta PA, Wallis DD, Chin TO, et al. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet 41: e56, 2004.","DOI":"10.1136\/jmg.2003.012880"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fujita D, Takeda N, Imai Y, Inuzuka R, Komuro I, Hirata Y. Pathophysiology and Japanese clinical characteristics in Marfan syndrome. Pediatr Int 56: 484-491, 2014.","DOI":"10.1111\/ped.12423"},{"key":"13","unstructured":"13. Fujita D, Takeda N, Imai Y, et al. Current status and future perspectives in the research of Marfan syndrome. Nihon Rinsho (Japanse Journal of Clinical Medicine) 72: 1163-1171, 2014 (in Japanese, Abstract in English)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bolar N, Van Laer L, Loeys BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr 24: 498-504, 2012.","DOI":"10.1097\/MOP.0b013e3283557d4c"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lindsay ME, Schepers D, Bolar NA, et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 44: 922-927, 2012.","DOI":"10.1038\/ng.2349"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Boileau C, Guo DC, Hanna N, et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44: 916-921, 2012.","DOI":"10.1038\/ng.2348"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mizuguchi T, Collod-Beroud G, Akiyama T, et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36: 855-860, 2004.","DOI":"10.1038\/ng1392"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37: 275-281, 2005.","DOI":"10.1038\/ng1511"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43: 121-126, 2011.","DOI":"10.1038\/ng.744"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121, 2006.","DOI":"10.1126\/science.1124287"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Habashi JP, Doyle JJ, Holm TM, et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332: 361-365, 2011.","DOI":"10.1126\/science.1192152"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Holm TM, Habashi JP, Doyle JJ, et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332: 358-361, 2011.","DOI":"10.1126\/science.1192149"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Groenink M, denHartog AW, Franken R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 34: 3491-3500, 2013.","DOI":"10.1093\/eurheartj\/eht334"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Ramirez F. Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production. J Biol Chem 285: 34126-34133, 2010.","DOI":"10.1074\/jbc.M110.125328"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nistala H, Lee-Arteaga S, Smaldone S, et al. Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol 190: 1107-1121, 2010.","DOI":"10.1083\/jcb.201003089"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chaudhry SS, Gazzard J, Baldock C, et al. Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. Hum Mol Genet 10: 835-843, 2001.","DOI":"10.1093\/hmg\/10.8.835"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nishimura A, Sakai H, Ikegawa S, et al. FBN2, FBN1, TGFBR1, and TGFBR2 analyses in congenital contractural arachnodactyly. Am J Med Genet A 143: 694-698, 2007.","DOI":"10.1002\/ajmg.a.31639"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T11:39:09Z","timestamp":1498217949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/10\/54_54.4280\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4280","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}